VAP-PRO-C6. Effectiveness and Tolerability of Venoactive Drugs in Combination Therapy in Patients With CVD (CEAP C6)
Не применимо
Завершено
NCT04757766
| Заболевание | Chronic Venous Insufficiency |
|---|
| Фаза | Не применимо |
|---|
| Спонсор | Servier Russia |
|---|
| Статус | Завершено |
|---|
| Участники | 350 участн. |
|---|
| Вмешательство | in daily everyday routine practice |
|---|
| Дата начала | 1.03.2021 |
|---|
| Дата завершения | 31.05.2022 |
|---|
| Публикация результатов | 19.09.2024 |
|---|
Кратко
The VAP-PRO-C6 is a Russian multicenter observational program to be implemented at the routine visits and assessments. The program will include patients with chronic venous disease of CEAP classes C6. This program is planned to be carried out in Russia in 2021-2022.
Eeffectiveness of Systemic Pharmacotherapy as a Part of Combination Therapy
6 months · Participants
| Patients With Venous Ulcers (CEAP Classes C6) Treated in Daily Clinical Practice | 243 Participants |
|---|
Eeffectiveness of Systemic Pharmacotherapy
6 months · Participants
| Patients With Venous Ulcers (CEAP Classes C6) Treated in Daily Clinical Practice | 247 Participants |
|---|
Открыть в BENITIONS
Открыть на ClinicalTrials.gov
Все исследования
Страница обобщает открытые данные ClinicalTrials.gov. Это не медицинская и не инвестиционная рекомендация. Обратитесь к врачу.